Safety and Efficacy of Mosunetuzumab: Experience in the Hospital Cardinale Giovanni Panico
Background/Objective: Follicular lymphoma (FL) is one of the most common indolent B-cell non-Hodgkin lymphomas (NHL) and is characterized by recurrent relapses despite advances in therapy. Bispecific antibodies that redirect T lymphocytes toward malignant B cells represent a major innovation in the...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI AG
2026-05-01
|
| Reeks: | Antibodies |
| Onderwerpen: | |
| Online toegang: | https://www.mdpi.com/2073-4468/15/3/40 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|